Mitochondrial stem cell pathology repair for alopecia
A novel mitochondrial medicine approach targeting autoimmune stem cell defects in hair follicle epithelial cells, with potential treatments for alopecia-related disorders.
Overview
This innovative approach targets mitochondrial dysfunction in hair follicle epithelial stem cells to address autoimmune pathologies like lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA). By repairing mitochondrial abnormalities and regulating excessive reactive oxygen species (ROS) production, this method holds promise for treating scarring hair loss disorders. The approach involves using PPARg agonists, thyrotropin-releasing hormone (TRH), and mitochondrial cannabinoid receptor-1 (mtCB1) stimulants to improve mitochondrial health and cellular function.
Technical specifications
This research leverages advanced organ culture assays to explore mitochondrial defects in hair follicle stem cells. Key pathways targeted include TRH receptors, PPARg, and mtCB1. The validation process involves repeating studies with increased sample sizes and employing a range of mitochondrial and stem cell senescence markers. Experimental induction of LPP/FFA pathology in scalp organ culture is used to test mitoprotective agents such as TRH, THC, pioglitazone, NAGED, and melatonin. The goal is to identify compounds that restore mitochondrial function and delay cellular aging.
Technology readiness level
This technology is at TRL 4, indicating that it has been validated in laboratory environments and is undergoing further testing to establish its effectiveness in preclinical models.
About University of Miami
The University of Miami is a private comprehensive research university based in Coral Gables with a major medical campus in Miami’s Health District and a marine science campus on Virginia Key. Industry partners engage through an integrated academic health system embedded alongside public hospitals, enabling clinical studies and translation at scale. A coastal campus co-located with NOAA facilities provides ocean and climate testbeds and long‑standing collaborations. Research is supported by competitive federal funding, including NIH and NSF, and by NOAA for marine and atmospheric work. A dedicated technology transfer office and an affiliated research park in the Health District offer IP support, licensing, startup formation, and lab and office space for collaborators.
delivered to your inbox.